Blogs
Market Commentary – Variant Perception – March, 2021
Cliches. The investing world is full of them. Wide-moat business. Intrinsic value. Be fearful when others are greedy. Skate to where the puck is going. Everyone has a plan until they get punched in the face.
Market Commentary – Fight Club – February, 2021
We looked at 2020 through the lens of 1999, specifically its worst music. Strangely, while the music from 1999 was dreadful, the films released that year were truly outstanding. This first month of 2021 reminded us of several classic films from 1999. With that, let’s Go (underrated cult classic).
Market Commentary – War Games – January, 2021
What is clear is that this year has been widely regarded “unprecedented”, an overused term Recently, we have seen many instances of “unprecedented” behavior and this last two weeks of market trading is another chapter in this unprecedented time. In order to enjoy this “meal of information” we are going to now “set the table,” and try to explain what is happening in the stock market.
Market Commentary – Parallel Universe – January, 2021
Though Neil DeGrasse Tyson would reprimand us, probably in a condescending manner, about ascribing significance to an arbitrary day commemorating one revolution of the earth around the sun, people, in general, put stock in the “new year.” The level of excitement associated with the arrival of 2021, closing the books on a year that will certainly live in infamy, is rivaled, at least in my lifetime, only by the mania associated with the end of 1999 as we stared into a new millennium.
Market Commentary – Action Park – December, 2020
The film: Class Action Park, demonstrates the sometimes-tragic consequences of not properly evaluating risk. . Located in New Jersey (everything is legal in New Jersey, per Hamilton), the park was the vision of a Wall Street veteran, Gene Mulvihill, whose firm was suspended by the SEC for fraud.
Imbed Biosciences Chases Nasal Spray to Combat Covid-19 Spread
Imbed’s nanoparticles were found to inactivate or kill about 99.9% of SARS-Cov-2 viruses in an experimental study run by Virology Research Services of London, according to a report seen by Bloomberg. To be sure, those results came from a study in a controlled lab and have not yet been replicated in a follow-on or human trial.
READY TO TALK?